
The HSE says all it can offer regarding the roll out of vaccine programme is uncertainty.
A decision is expected today on whether the AstraZeneca vaccine will be approved for use in Europe.
It's possible the European Medicines Agency will place an age restriction on the vaccine, due to insufficient data regarding it's effect on people aged over 65.
Meanwhile the row between the EU and AstraZeneca over vaccine supply has yet to be resolved.
HSE CEO Paul Reid says it will follow whatever advice the EMA offers.
